Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy

Hagop Kantarjian, Susan O'Brien, Guillermo Garcia-Manero, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Jianqin Shan, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences